Somatic cells such as skin cells can be directly converted into induced motor neurons (iMNs) via direct conversion technology.
SuPine Therapeutics developed the technology for generating a large number of functional iMNs that exhibit therapeutic effects in spinal cord injury model.
Lee et al., eLife (2020)
Direct conversion through self-renewing iMN-intermediate cells (iMNICs) enables large production of iMNs from somatic cells. iMNs express motor neuron-specific markers (HB9, ISL1, TUJ1, MAP2, NKX6.1 and CHAT) and synaptic markers (SYN1 and SV2). iMNs exhibit mature functionality such as the formation of neuromuscular junctions(NMJs) with myotubes. iMNs showed a high degree of similarity with wild-type MNs or fetal spinal cord tissues.
iMNs are electrophysiologically mature showing tetrodotoxin(TTX)-sensitive sodium currents.
iMN transplantation significantly improved recovery of hindlimb motor functionality in animal spinal cord injury model.
iMN-transplanted tissue show less cavity of injured site compared to control. Transplanted iMNs expressed neuronal marker and were surrounded by host myelinating oligodendrocytes